The SEP licensing and litigation landscape has continued to evolve in the latter half of 2025, shaped by several significant global ...

GEN2 was evaluated in adult patients with advanced solid tumors in an intravenous dose escalation Phase 1 study GEN2 is well-tolerated, with no Dose Limiting Toxicity or treatment-related ...

Quantinuum launches Helios, a 98-qubit system that breaks fidelity records and brings real-time, enterprise-ready quantum ...

The authors used a Bayesian modeling framework to fit behavior and serotonin neuron activity to reward history across multiple timescales. A key goal was to distinguish value coding from other ...

This investigation, conducted with support from the Georgian CERT, uncovered new tools and techniques used by the Curly COMrades threat actor. It established covert, long-term access to victim ...